These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6134999)

  • 1. Plasma fractionation methods and T-cell subsets in haemophilia.
    Lee CA; Janossy G; Ashley J; Kernoff PB
    Lancet; 1983 Jul; 2(8342):158-9. PubMed ID: 6134999
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor IX activity and factor IX antigen in haemophilia B carriers.
    Elödi S
    Thromb Res; 1975 Jan; 6(1):39-51. PubMed ID: 1114478
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS in hemophilia.
    Hilgartner MW; Aledort LM
    Ann N Y Acad Sci; 1984; 437():466-71. PubMed ID: 6242002
    [No Abstract]   [Full Text] [Related]  

  • 4. T-cell subsets in hemophilia.
    N Engl J Med; 1983 May; 308(21):1291-3. PubMed ID: 6405270
    [No Abstract]   [Full Text] [Related]  

  • 5. A simple inhibitor screen is more sensitive than a Bethesda assay in monitoring for the development of inhibitors in haemophilia A and B.
    Keeling D; Beavis J; Sukhu K
    Br J Haematol; 2005 Mar; 128(6):885. PubMed ID: 15755295
    [No Abstract]   [Full Text] [Related]  

  • 6. Gm types and antibodies in multitransfused haemophiliacs.
    Kernoff PB; Bowell PJ
    Br J Haematol; 1973 Apr; 24(4):443-50. PubMed ID: 4715141
    [No Abstract]   [Full Text] [Related]  

  • 7. Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population.
    Carr R; Veitch SE; Edmond E; Peutherer JF; Prescott RJ; Steel CM; Ludlam CA
    Lancet; 1984 Jun; 1(8392):1431-4. PubMed ID: 6145879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased helper-suppressor cell ratios following treatment with blood products: factor VIII and IX concentrates and fresh frozen plasma.
    Ragni MV; Lewis JH; Spero JA; Bontempo FA; Rabin BS
    Scand J Haematol Suppl; 1984; 40():371. PubMed ID: 6236552
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquired immunodeficiency syndrome, hepatitis, and haemophilia.
    Jones P
    Br Med J (Clin Res Ed); 1983 Dec; 287(6407):1737-8. PubMed ID: 6416569
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of allogeneic cytotoxic activity by factor VIII or IX concentrates.
    Soria AG; Bouzas MB; Anselmo A; Ruibal-Ares BH
    Haematologica; 1991; 76(1):33-7. PubMed ID: 1829058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple and accurate bedside diagnostic kit for determining haemophilia A and B: a revised version.
    Sasanakul W; Kadegasem P; Chaiyaratana W; Wongwerawattanakoon P; Sirachainan N; Chuansumrit A
    Haemophilia; 2013 Jan; 19(1):e48-9. PubMed ID: 23088419
    [No Abstract]   [Full Text] [Related]  

  • 12. Acquired immunodeficiency syndrome (AIDS) in hemophilia.
    Evatt BL; Chorba TL
    Clin Lab Med; 1984 Jun; 4(2):333-44. PubMed ID: 6437735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
    Lechner K; Niessner H; Bettelheim P; Deutsch E; Fasching I; Fuhrmann M; Hinterberger W; Korninger C; Neumann E; Liszka K
    Thromb Haemost; 1983 Aug; 50(2):552-6. PubMed ID: 6314582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1.
    Girolami A; Dal Bo Zanon R; Procidano M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):863-71. PubMed ID: 6176512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemophilia-associated AIDS in the United States, 1981 to September 1987.
    Stehr-Green JK; Holman RC; Jason JM; Evatt BL
    Am J Public Health; 1988 Apr; 78(4):439-42. PubMed ID: 3126675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS and haemophilia: morbidity and morality in a well defined population.
    Jones P; Hamilton PJ; Bird G; Fearns M; Oxley A; Tedder R; Cheingsong-Popov R; Codd A
    Br Med J (Clin Res Ed); 1985 Sep; 291(6497):695-9. PubMed ID: 2994801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
    Ahnström J; Berntorp E; Lindvall K; Björkman S
    Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitors and "bypass" therapy in hemophilia].
    Fukutake K; Fukutake K
    Nihon Rinsho; 1981; 39(12):3688-99. PubMed ID: 6803034
    [No Abstract]   [Full Text] [Related]  

  • 19. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
    Allain JP
    Nouv Rev Fr Hematol; 1972; 12(2):241-9. PubMed ID: 4264617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.